These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 23140358)

  • 21. Synthesis and biological evaluation of RGD and isoDGR peptidomimetic-α-amanitin conjugates for tumor-targeting.
    Bodero L; López Rivas P; Korsak B; Hechler T; Pahl A; Müller C; Arosio D; Pignataro L; Gennari C; Piarulli U
    Beilstein J Org Chem; 2018; 14():407-415. PubMed ID: 29520305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual-targeting liposomes with active recognition of GLUT
    Pu Y; Zhang H; Peng Y; Fu Q; Yue Q; Zhao Y; Guo L; Wu Y
    Eur J Med Chem; 2019 Dec; 183():111720. PubMed ID: 31553933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Co-delivery of TRAIL gene enhances the anti-glioblastoma effect of paclitaxel in vitro and in vivo.
    Zhan C; Wei X; Qian J; Feng L; Zhu J; Lu W
    J Control Release; 2012 Jun; 160(3):630-6. PubMed ID: 22410115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and biological evaluation of potent alphavbeta3-integrin receptor antagonists.
    Dijkgraaf I; Kruijtzer JA; Frielink C; Soede AC; Hilbers HW; Oyen WJ; Corstens FH; Liskamp RM; Boerman OC
    Nucl Med Biol; 2006 Nov; 33(8):953-61. PubMed ID: 17127167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro and in vivo evaluation of a paclitaxel conjugate with the divalent peptide E-[c(RGDfK)2] that targets integrin alpha v beta 3.
    Ryppa C; Mann-Steinberg H; Biniossek ML; Satchi-Fainaro R; Kratz F
    Int J Pharm; 2009 Feb; 368(1-2):89-97. PubMed ID: 18992308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. αvβ3 Integrin-Targeted Peptide/Peptidomimetic-Drug Conjugates: In-Depth Analysis of the Linker Technology.
    Dal Corso A; Pignataro L; Belvisi L; Gennari C
    Curr Top Med Chem; 2016; 16(3):314-29. PubMed ID: 26126915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting.
    Yin T; Wu Q; Wang L; Yin L; Zhou J; Huo M
    Mol Pharm; 2015 Aug; 12(8):3020-31. PubMed ID: 26086430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination of RGD compound and low-dose paclitaxel induces apoptosis in human glioblastoma cells.
    Chang MW; Lo JM; Juan HF; Chang HY; Chuang CY
    PLoS One; 2012; 7(5):e37935. PubMed ID: 22655084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrin-targeted delivery into cancer cells of a Pt(IV) pro-drug through conjugation to RGD-containing peptides.
    Massaguer A; González-Cantó A; Escribano E; Barrabés S; Artigas G; Moreno V; Marchán V
    Dalton Trans; 2015 Jan; 44(1):202-12. PubMed ID: 25369773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kiss and Run: Promoting Effective and Targeted Cellular Uptake of a Drug Delivery Vehicle Composed of an Integrin-Targeting Diketopiperazine Peptidomimetic and a Cell-Penetrating Peptide.
    Feni L; Parente S; Robert C; Gazzola S; Arosio D; Piarulli U; Neundorf I
    Bioconjug Chem; 2019 Jul; 30(7):2011-2022. PubMed ID: 31243977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of one-bead one-compound combinatorial library technology to discover high-affinity αvβ3 integrin and cancer targeting arginine-glycine-aspartic acid ligands with a built-in handle.
    Xiao W; Wang Y; Lau EY; Luo J; Yao N; Shi C; Meza L; Tseng H; Maeda Y; Kumaresan P; Liu R; Lightstone FC; Takada Y; Lam KS
    Mol Cancer Ther; 2010 Oct; 9(10):2714-23. PubMed ID: 20858725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Binding and uptake of novel RGD micelles to the αvβ3 integrin receptor for targeted drug delivery.
    Raj A; Saraf P; Javali NM; Li X; Jasti B
    J Drug Target; 2014 Jul; 22(6):518-27. PubMed ID: 24611965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PET/MRI dual-modality tumor imaging using arginine-glycine-aspartic (RGD)-conjugated radiolabeled iron oxide nanoparticles.
    Lee HY; Li Z; Chen K; Hsu AR; Xu C; Xie J; Sun S; Chen X
    J Nucl Med; 2008 Aug; 49(8):1371-9. PubMed ID: 18632815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. (64)Cu-labeled tetrameric and octameric RGD peptides for small-animal PET of tumor alpha(v)beta(3) integrin expression.
    Li ZB; Cai W; Cao Q; Chen K; Wu Z; He L; Chen X
    J Nucl Med; 2007 Jul; 48(7):1162-71. PubMed ID: 17574975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Favorable biokinetic and tumor-targeting properties of 99mTc-labeled glucosamino RGD and effect of paclitaxel therapy.
    Jung KH; Lee KH; Paik JY; Ko BH; Bae JS; Lee BC; Sung HJ; Kim DH; Choe YS; Chi DY
    J Nucl Med; 2006 Dec; 47(12):2000-7. PubMed ID: 17138743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrin αvβ3 targeting activity study of different retro-inverso sequences of RGD and their potentiality in the designing of tumor targeting peptides.
    Liu Y; Mei L; Yu Q; Zhang Q; Gao H; Zhang Z; He Q
    Amino Acids; 2015 Dec; 47(12):2533-9. PubMed ID: 26173509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insight to the binding mode of triazole RGD-peptidomimetics to integrin-rich cancer cells by NMR and molecular modeling.
    Vasile F; Menchi G; Lenci E; Guarna A; Potenza D; Trabocchi A
    Bioorg Med Chem; 2016 Mar; 24(5):989-94. PubMed ID: 26818999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
    Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
    J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization and evaluation of DOTA-conjugated Bombesin/RGD-antagonists for prostate cancer tumor imaging and therapy.
    Stott Reynolds TJ; Schehr R; Liu D; Xu J; Miao Y; Hoffman TJ; Rold TL; Lewis MR; Smith CJ
    Nucl Med Biol; 2015 Feb; 42(2):99-108. PubMed ID: 25459113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of subnanomolar arginine-glycine-aspartate-based alphaVbeta3/alphaVbeta5 integrin binders embedding 4-aminoproline residues.
    Zanardi F; Burreddu P; Rassu G; Auzzas L; Battistini L; Curti C; Sartori A; Nicastro G; Menchi G; Cini N; Bottoncetti A; Raspanti S; Casiraghi G
    J Med Chem; 2008 Mar; 51(6):1771-82. PubMed ID: 18303826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.